Opening of conference)
New therapy options/possibilities from a patient's perspective (Anita Waldmann, Ruesselsheim, Germany)
How digital tools can improve patient care (Domas Vaitiekus, Kaunas, Lithuania)
Autologous hematopoietic cell transplantation for myeloma (Dr. Milda Rudžianskienė, Kaunas, Lithuania)
Graft manipulation procedures in matched or mismatched stem cell transplantation with following immune therapy (Prof. Peter Lang, Tubingen, Germany)
Cellular therapy for the treatment of neurological diseases (Prof. Frank Edenhofer, Innsbruck, Austria)
Can we induce treatment free remissions with molecular therapy in chronic myelogenous leukemia (Assoc. Prof. Rolandas Gerbutavičius, Kaunas, Lithuania)
Concluding remarks (Prof. Dietger Niederwieser, Leipzig, Germany)
JACIE regulation in Europe and worldwide (Eoin McGrath, Barcelona, Spain)
The first successful cellular therapy: allogeneic stem cell transplantation (Prof. Dietger Niederwieser, Leipzig, Germany)
Multiple myeloma: a complex disease (Prof. Wieslaw Wiktor Jedrzejczak, Warsaw, Poland)
Autologous stem cell transplantation in lymphoma (Prof. Peter Dreger, Heidelberg, Germany)
Applying genome editing technologies for target identification, validation and novel treatment combinations (Prof. Roderick L. Beijersbergen, Amsterdam, Netherlands)
Acute lymphocytic leukemia treatment protocols (Dr. Vladan Vucinic, Leipzig, Germany)
Cellular therapy for immune modulation (Eglė Simaškienė, Kaunas, Lithuania)